Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Multi-country, Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial to Evaluate the Immunogenicity and Tolerability of Sabin Strain Inactivated Poliovirus Vaccine Administered With or Without Routine Infant Vaccines

Next Previous
Trial Profile

A Multi-country, Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial to Evaluate the Immunogenicity and Tolerability of Sabin Strain Inactivated Poliovirus Vaccine Administered With or Without Routine Infant Vaccines

Status: Completed
Phase of Trial: Phase III

Latest Information Update: 22 Dec 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Poliovirus vaccine inactivated Intravacc/Sinovac/WHO (Primary) ; DTP-HepB-IPV-Hib vaccine LG Chem; Pneumococcal 10-valent vaccine conjugate; Rotavirus vaccine
  • Indications Poliomyelitis
  • Focus Adverse reactions; Pharmacodynamics; Registrational
  • Sponsors Sinovac Biotech

Most Recent Events

  • 18 Dec 2025 Actual primary completion date is 13 Feb 2025.
  • 18 Dec 2025 Status changed from recruiting to completed.
  • 25 Sep 2023 Status changed from not yet recruiting to recruiting.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top